Clinical efficacy of J-type acupotomy in the treatment of flexor tendon stenosing tenosynovitis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100004232

Enrollment

Unknown

Registered

2020-10-10

Start date

2020-11-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flexor tendon stenosing tenosynovitis

Interventions

Group B:Ordinary needle knife

Group C:J type needle knife

Group A:Partially closed

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The patient meets the diagnostic criteria for stenosing tenosynovitis of the middle flexor tendon; 2. Patients aged 18 to 60 years, regardless of gender; 3. All patients have informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with flexor tendon stenosing tenosynovitis without snapping and locking symptoms; 2. With severe liver, kidney, hematopoietic system, endocrine system diseases, osteoporosis, malignant tumors, severe trauma, myocardial infarction, sequelae of cerebral hemorrhage or other severe primary diseases and mental illness; 3. Those who have received or are receiving other treatments in the past month, which may affect the treatment effect; 4. Those who cannot cooperate with needle knife treatment; 5. Those who have bleeding tendency, etc. are not suitable for use needle knife therapy; 6. Allergic to lidocaine.

Design outcomes

Primary

Measure	Time frame
Tendon function evaluation standard;	—

Secondary

Measure	Time frame
Visual analog scale;	—

Countries

china

Contacts

Public ContactXiong Wei

Nanchang Hongdu Hospital of TCM

330754036@qq.com+86 15979030828

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026